MedPath
HSA Approval

Sterofundin ISO solution for infusion

SIN13890P

Sterofundin ISO solution for infusion

Sterofundin ISO solution for infusion

November 15, 2010

B. BRAUN SINGAPORE PTE LTD

B. BRAUN SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantB. BRAUN SINGAPORE PTE LTD
Licence HolderB. BRAUN SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INFUSION, SOLUTION

INTRAVENOUS

Manufacturer Information

B. Braun Singapore Pte Ltd.

B.Braun Melsungen AG

B. Braun Medical SA

Active Ingredients

Magnesium Chloride Hexahydrate

0.2033g/1000ml

Magnesium chloride

Potassium Chloride

0.2984g/1000ml

Potassium chloride

Sodium Chloride

6.799g/1000ml

Sodium chloride

Calcium Chloride Dihydrate

0.3675g/1000ml

Calcium chloride

Malic Acid

0.671g/1000ml

Malic acid

Sodium Acetate Trihydrate

3.266g/1000ml

Sodium acetate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sterofundin ISO solution for infusion - HSA Approval | MedPath